 |
Every year an estimated 20 million HEV infections occur worldwide, leading to more than three million symptomatic cases of Hepatitis E. The World Health Organization estimates that Hepatitis E caused approximately 44 000 deaths in 2015.
Recent seroprevalence studies indicate high prevalence of HEV infection among healthy populations in some industrial countries with historically low occurrence of Hepatitis E including the US, Japan and Europe and not only in tdeveloping countries with limited or no access to essential water, sanitation, hygiene and health services.
In patients infected with HEV, IgM antibodies typically appear first, followed by IgG seroconversion. The level of IgM antibodies declines rapidly in the acute phase of the infection; the IgG antibodies are present for up to 14 years.
Beijing Wantai offers diagnostic products to detect Hepatitis E.
Beijing Wantai’s ELISA kits are intended for use in clinical laboratories for diagnosis and management of the Hepatitis E virus infections
The anti-HEV antigen (Ag)–specific ELISA offers an inexpensive alternative to PCR.
ELISA Tests: View Information Pack
Cat # WE-7296 Wantai HEV-IgG ELISA 
HEV-IgG ELISA is used for qualitative determination of IgG antibodies against HEV.
Cat # WE-7196 Wantai HEV-IgM ELISA
HEV-IgG ELISA is used for qualitative determination of IgM antibodies against HEV.
Cat # WE-7596 Wantai HEV-Ag ELISAPlus
HEV-Ag ELISAPlus is an enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of the Hepatitis E virus antigen.
DBA-ITALIA Srl
Via Umbria 10
20090 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535